Dentsply Sirona/$XRAY
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Dentsply Sirona
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantology. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers.
- Ticker
- $XRAY
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 14,000
- Headquarters
- Charlotte, United States
- Website
- www.dentsplysirona.com
Dentsply Sirona Metrics
BasicAdvanced
$1.9B
-
-$0.61
0.86
$0.16
6.71%
Price and volume
Market cap
$1.9B
Beta
0.86
52-week high
$14.76
52-week low
$8.14
Average daily volume
5M
Dividend rate
$0.16
Financial strength
Current ratio
1.625
Quick ratio
0.657
Long term debt to equity
1.539
Total debt to equity
1.702
Interest coverage (TTM)
1.59%
Profitability
EBITDA (TTM)
506
Gross margin (TTM)
50.52%
Net profit margin (TTM)
-3.38%
Operating margin (TTM)
4.67%
Effective tax rate (TTM)
-34.07%
Revenue per employee (TTM)
$260,000
Management effectiveness
Return on assets (TTM)
1.93%
Return on equity (TTM)
-8.62%
Valuation
Price to revenue (TTM)
0.533
Price to book
1.4
Price to tangible book (TTM)
-3.17
Price to free cash flow (TTM)
18.49
Free cash flow yield (TTM)
5.41%
Free cash flow per share (TTM)
0.516
Dividend yield (TTM)
1.68%
Forward dividend yield
6.71%
Growth
Revenue change (TTM)
-1.35%
Earnings per share change (TTM)
-86.23%
3-year revenue growth (CAGR)
-3.16%
10-year revenue growth (CAGR)
0.44%
3-year earnings per share growth (CAGR)
-15.37%
10-year earnings per share growth (CAGR)
-10.81%
3-year dividend per share growth (CAGR)
-33.54%
10-year dividend per share growth (CAGR)
-6.25%
What the Analysts think about Dentsply Sirona
Analyst ratings (Buy, Hold, Sell) for Dentsply Sirona stock.
Analyst projections of the future price of Dentsply Sirona stock.
Bulls say / Bears say
Wellspect delivered record quarterly sales, up 10.1% year on year, and completed the US launch of its Surity urinary-care range. This growing business gives Dentsply a source of momentum beyond its pressured dental segments. (Dentsply Sirona)
Dentsply has signed seven North American distribution agreements this year, while US sales-force vacancies have fallen from more than 20% to mid-single-digit levels. Better customer coverage could help its products reach more practices as the turnaround progresses. (Dentsply Sirona, Yahoo Finance)
The FDA-cleared Smart View–Detect AI tool is available through DS Core for compatible existing as well as new imaging systems. That gives Dentsply a way to add digital features to its installed base without relying solely on new equipment sales. (Dental Tribune)
Third-quarter sales fell 7.6% year on year, and Dentsply cut its 2026 adjusted EPS outlook to $1.20–$1.30 from $1.40–$1.50. The weaker results and lower forecast point to a recovery that is taking longer than expected. (Dentsply Sirona)
Third-quarter adjusted EBITDA margin fell to 17.3% from 18.4%, while free cash flow was zero versus $40 million a year earlier. Results also included a $39 million inventory-accounting benefit that the company does not expect to recur, clouding the underlying earnings trend. (Dentsply Sirona)
Dentsply amended its credit and note agreements, raising permitted leverage limits and temporarily restricting certain borrowing and payments. Those tighter lender arrangements leave less room for error while the company works to improve performance. (StockTitan)
Data summarised monthly by Lightyear AI. Last updated on 6 Nov 2026.
Dentsply Sirona Financial Performance
Revenues and expenses
Dentsply Sirona Earnings Performance
Company profitability
Upcoming events
No upcoming events
Dentsply Sirona News
AllArticlesVideos
Funds containing Dentsply Sirona
AllUSDEURGBP
Fund name | Fund size | $XRAY weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.07% |
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.07% |
SPDR S&P 400 US Mid Cap$SPY4 | $6.4B | 0.06% |
SPDR S&P 400 US Mid Cap£SPX4 | $6.4B | 0.06% |
SPDR MSCI USA Small Cap Value Weighted$USSC | $1.1B | 0.05% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.